<DOC>
	<DOC>NCT01967966</DOC>
	<brief_summary>This 2-arm, open-label, non-randomized study will investigate the absolute bioavailability, pharmacokinetics, mass balance, and routes of elimination of GDC-0032 as well as its safety in healthy volunteers. Patients will receive either a single oral dose of GDC-0032 followed by a 14C-labeled IV dose of GDC-0032 or a single oral dose of 14C-labelled GDC-0032.</brief_summary>
	<brief_title>A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Body Mass Index (BMI) 18 to 32 kg/m2, inclusive; Healthy, as judged by physician from medical history, 12lead ECG, vital signs, and clinical laboratory evaluations; Agree to use effective contraceptive methods as defined by protocol; Negative hepatitis panel and HIV screen; Sufficient bowel movements (minimum of 1 per day). History or clinical manifestation of: any major medical disorders; any food/drug/substance allergies; History of stomach or intestinal surgery or resection except for appendectomy and/or hernia repair; History of alcoholism or drug addiction within 1 year prior to drug administration; Tobacco or nicotine use within 6 months prior to study start; Chronic use of gastric acid inhibitors within 6 months of study start or use of gastric acid inhibitors and/or antacids within 1 month prior to drug administration; Evidence of malabsorption syndrome or other condition interfering with gastrointestinal absorption; Inability or unwillingness to swallow capsules; Participation in a drug study in which a drug was administered within 30 days prior to study start; Participation in more than one radiolabeled drug study within 12 months preceding drug administration. The previous radiolabeled study drug must have been received more than 6 months prior to this study, and the total exposure from this study and the previous study is less than 5000 mrem whole body annual exposure; Exposure to significant radiation within 12 months prior to study start.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>